Screening of plasma IL-6 and IL-17 in Bangladeshi lung cancer patients.

Shill, Manik Chandra; Biswas, Bisshojit; Kamal, Sadia; Islam, Moriam; Rima, Sharmin Sultana; Ferdausi, Farhana Afrin; Chowdhury, Qamruzzaman; Reza, Hasan Mahmud; Bepari, Asim Kumar

Shill, Manik Chandra; Biswas, Bisshojit; Kamal, Sadia; Islam, Moriam; Rima, Sharmin Sultana; Ferdausi, Farhana Afrin; Chowdhury, Qamruzzaman; Reza, Hasan Mahmud; Bepari, Asim Kumar.

Afiliación

Shill MC; Department of Pharmaceutical Sciences, North South University, Dhaka, 1229, Bangladesh.
Biswas B; Department of Pharmaceutical Sciences, North South University, Dhaka, 1229, Bangladesh.
Kamal S; Department of Pharmaceutical Sciences, North South University, Dhaka, 1229, Bangladesh.
Islam M; Department of Pharmaceutical Sciences, North South University, Dhaka, 1229, Bangladesh.
Rima SS; Department of Pharmaceutical Sciences, North South University, Dhaka, 1229, Bangladesh.
Ferdausi FA; Ahsania Mission Cancer and General Hospital (AMCGH), Dhaka, 1230, Bangladesh.
Chowdhury Q; Ahsania Mission Cancer and General Hospital (AMCGH), Dhaka, 1230, Bangladesh.
Reza HM; Department of Pharmaceutical Sciences, North South University, Dhaka, 1229, Bangladesh.
Bepari AK; Department of Pharmaceutical Sciences, North South University, Dhaka, 1229, Bangladesh.

Heliyon ; 9(10): e20471, 2023 Oct.

Article en En | MEDLINE | ID: mdl-37810816

Palabras clave

Adenocarcinoma; Cancer diagnosis; Inflammation; Interleukin

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Contexto en salud: 6_ODS3_enfermedades_notrasmisibles Problema de salud: 6_trachea_bronchus_lung_cancer Tipo de estudio: Diagnostic_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Idioma: En Revista: Heliyon Año: 2023 Tipo del documento: Article País de afiliación: Bangladesh

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google